Bourne Partners vs Ziegler
Comparing two boutique M&A advisors · Last updated April 2, 2025
| Attribute | Bourne Partners | Ziegler |
|---|---|---|
| Type | Industry specialist | Industry specialist |
| HQ | Charlotte, NC | Chicago, IL |
| Founded | 2001 | 1902 |
| Sector focus | Healthcare, Pharma | Healthcare, Senior Living |
| Deal size | $25M-$500M | $25M-$500M |
| Senior team |
|
|
| Rating | Locked | Locked |
| Reviews | 0 verified | 0 verified |
Choosing between Bourne Partners and Ziegler
Bourne Partners and Ziegler both work in Healthcare. Founders running a sell-side process in those categories often see both names on their advisor longlist, which is why this comparison comes up. Both firms position themselves as industry specialist advisors, so the choice is less about category and more about pattern recognition, senior attention, and process fit.
Bourne Partners is headquartered in Charlotte, NC and was founded in 2001, while Ziegler operates out of Chicago, IL and was founded in 1902. Geography matters here: Bourne Partners's Charlotte relationships and Ziegler's Chicago relationships will overlap on national strategics but diverge on the regional private equity buyer set most likely to push price. On deal-size focus, Bourne Partners states $25M-$500M while Ziegler states $25M-$500M. Beyond shared coverage, Bourne Partners also reaches into Pharma, while Ziegler extends into Senior Living.
For founders deciding between Bourne Partners and Ziegler, the honest recommendation is to take a working session with each named partner before signing. Read the firm-level reviews on BankerNotes for the pattern that matters most: did the partner who pitched the mandate run the buyer calls and final negotiations, or did the work slide down the org chart by week six. That pattern, more than league-table position, is what separates a good outcome from a mediocre one.
Bourne Partners is a industry specialist headquartered in Charlotte, NC and founded in 2001. The firm focuses on Healthcare, Pharma and typically advises on transactions in the $25M-$500M range. Key dealmakers include Ba...
Ziegler is a industry specialist headquartered in Chicago, IL and founded in 1902. The firm focuses on Healthcare, Senior Living and typically advises on transactions in the $25M-$500M range. Key dealmakers include Tim O...
Frequently asked questions
- What is the main difference between Bourne Partners and Ziegler?
- Bourne Partners is a industry specialist HQ'd in Charlotte, NC (founded 2001), focused on Healthcare, Pharma, with a typical deal range of $25M-$500M. Ziegler is a industry specialist HQ'd in Chicago, IL (founded 1902), focused on Healthcare, Senior Living, with a typical deal range of $25M-$500M. Beyond those facts, the most reliable differentiator is senior banker attention, which BankerNotes reviews are designed to surface.
- Which firm has better founder reviews, Bourne Partners or Ziegler?
- Bourne Partners's current rating is Locked (reviews unlock after five verified founders submit ratings). Ziegler's current rating is Locked (reviews unlock after five verified founders submit ratings). Read the individual firm profiles for the full review breakdown.
- Should I shortlist both Bourne Partners and Ziegler?
- For most founders evaluating sell-side advisors with overlapping sector and deal-size fit, putting both on a shortlist is reasonable. The point of a bake-off is to test how the senior team behaves under pressure, how the firm shapes the buyer universe, and how it handles a difficult diligence question. Treat the shortlist as an interview, not a beauty contest.
- How does BankerNotes verify reviews of Bourne Partners and Ziegler?
- Every review is submitted by a founder who confirms they hired the firm as their sell-side advisor. We verify the reviewer privately using work email, LinkedIn, and approximate engagement timing. The verified identity is never published. Only the rating, written review, and a generic sector label appear on the public page.
Related advisor comparisons
Browse sectors covered
Last updated: April 2, 2025